Metronomic capecitabine showed no significant myelosuppression. A and... | Download Scientific Diagram
Metronomic chemotherapy in breast cancer | Semantic Scholar
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
PDF) Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
Elderly Woman with Triple-negative Metastatic Breast Cancer Successfully Treated with Metronomic Capecitabine | Anticancer Research
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer - Chai - Thoracic Cancer - Wiley Online Library
Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Metronomic Chemotherapy for Triple-Negative Breast Cancer
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - ScienceDirect
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study – topic of research paper in Clinical
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
PDF) Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report – topic of research paper in Clinical medicine.
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
Low-Dose Metronomic Capecitabine (Xeloda) for Treatment ofMetastatic Cholangiocarcinoma : Case Reports and Review of the Literature | Semantic Scholar
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial - The Breast
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
Possible immunosuppressive mechanisms of metronomic capecitabine on T... | Download Scientific Diagram
